Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for Hemodynamic Stability in OPCAB
NCT04598191Unknown
- Sponsor
- Yonsei University
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of iloprost in hemodynamic instability (2 arms), sponsored by Yonsei University. Primary endpoint: Intraoperative cardiac index. Status: unknown.
02
Drugs
iloprost
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT04598191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598191.